Phase 3, master-protocol, randomised double-blind placebo-controlled trial of retatrutide in participants with type 2 diabetes mellitus who also have obesity or overweight. Status: completed (actual completion 2026-06-16); no structured results record posted to ClinicalTrials.gov yet, and this Record entry does not carry any topline efficacy figures for TRIUMPH-2 — those have not yet been independently verified for publication here.
Checked 2026-08-08 · next review due 2026-11-08
← Back to the Record